{"id":"W3167842465","doi":"10.1016/s2352-4642(21)00100-0","title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study","year":2021,"lang":"en","type":"article","venue":"The Lancet Child & Adolescent Health","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Ionis Pharmaceuticals; Biogen","keywords":"Medicine; Spinal muscular atrophy; Interim analysis; Tolerability; Adverse effect; Cohort; Pediatrics; Clinical endpoint; Cohort study; Clinical trial; Surgery; Physical therapy; Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002196198,0.001854063,0.003516133,0.0004215295,0.0003993101,0.001233216,0.001069389,0.002255532,0.003228907],"category_scores_gemma":[0.001393975,0.0005534904,0.002468389,0.0003438193,0.0009305621,0.001100746,0.0003540755,0.003076948,0.0008002475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009246502,"about_ca_system_score_gemma":0.0009315716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001644739,"about_ca_topic_score_gemma":0.005025671,"domain_scores_codex":[0.9993426,0.0002924549,0.00004028516,0.0001005064,0.00007030152,0.0001538389],"domain_scores_gemma":[0.9991608,0.0002663432,0.0001416829,0.00008988076,0.0000772834,0.0002639224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7689899,0.03485733,0.00429011,0.003108858,0.005432897,0.0005214278,0.0007104038,0.003775208,0.02164949,0.0004378309,0.004135523,0.1520911],"study_design_scores_gemma":[0.7006044,0.2760907,0.01389983,0.0002441961,0.001403642,0.0003650571,0.0001946141,0.001116286,0.001928724,0.0003714306,0.003706214,0.00007506272],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846584,0.009973397,0.0007404414,0.0005791383,0.0002284873,0.001251747,0.0008326266,0.000118666,0.001617095],"genre_scores_gemma":[0.9816746,0.007653309,0.002350055,0.001306954,0.0001441873,0.001305517,0.001690635,0.00005767648,0.00381703],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003516133,"threshold_uncertainty_score":0.01161474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09361085090664703,"score_gpt":0.4152197734540647,"score_spread":0.3216089225474177,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}